X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7107) 7107
Publication (789) 789
Book Chapter (79) 79
Dissertation (44) 44
Conference Proceeding (41) 41
Magazine Article (22) 22
Book Review (18) 18
Newspaper Article (14) 14
Newsletter (10) 10
Streaming Video (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
benzoxazines (2965) 2965
humans (2889) 2889
male (2538) 2538
index medicus (2350) 2350
animals (2003) 2003
hiv infections - drug therapy (1628) 1628
female (1627) 1627
pharmacology & pharmacy (1322) 1322
benzoxazine (1218) 1218
benzoxazines - pharmacology (1197) 1197
morpholines - pharmacology (1185) 1185
naphthalenes - pharmacology (1179) 1179
adult (1168) 1168
rats (1131) 1131
infectious diseases (946) 946
efavirenz (916) 916
anti-hiv agents - therapeutic use (881) 881
benzoxazines - therapeutic use (875) 875
polymer science (866) 866
neurosciences (838) 838
middle aged (754) 754
benzoxazines - administration & dosage (683) 683
hiv (679) 679
analysis (611) 611
reverse transcriptase inhibitors - therapeutic use (609) 609
benzoxazin (599) 599
immunology (599) 599
dose-response relationship, drug (587) 587
polymers (579) 579
mice (575) 575
polybenzoxazines (561) 561
polymerization (546) 546
drug therapy, combination (533) 533
pyrazoles - pharmacology (517) 517
piperidines - pharmacology (513) 513
oxazines - therapeutic use (493) 493
benzoxazines - adverse effects (487) 487
rats, sprague-dawley (483) 483
anti-hiv agents - adverse effects (479) 479
treatment outcome (477) 477
anti-hiv agents - administration & dosage (454) 454
benzoxazines - chemistry (452) 452
monomers (450) 450
hiv infections - virology (438) 438
cannabinoids - pharmacology (437) 437
viral load (436) 436
antiretroviral therapy (433) 433
ring-opening polymerization (428) 428
antiviral agents (424) 424
virology (406) 406
polybenzoxazine (400) 400
hiv-1 - drug effects (367) 367
chemistry, multidisciplinary (366) 366
cd4 lymphocyte count (364) 364
benzoxazines - pharmacokinetics (363) 363
rats, wistar (358) 358
therapy (353) 353
drug interactions (347) 347
time factors (340) 340
biochemistry & molecular biology (338) 338
article (336) 336
resins (329) 329
research (324) 324
microbiology (323) 323
nevirapine (323) 323
pharmacokinetics (318) 318
reverse transcriptase inhibitors - adverse effects (318) 318
drug therapy (315) 315
hiv infection (300) 300
chemistry, organic (299) 299
receptors, cannabinoid (296) 296
brain (293) 293
hiv-1 (293) 293
receptor, cannabinoid, cb1 - agonists (293) 293
cannabinoids (291) 291
nevirapine - therapeutic use (291) 291
thermal properties (278) 278
reverse transcriptase inhibitors - administration & dosage (270) 270
adolescent (268) 268
aged (268) 268
oxazines - adverse effects (266) 266
antiretroviral therapy, highly active (264) 264
cannabinoid (263) 263
endocannabinoids (259) 259
antiretroviral drugs (257) 257
tenofovir (257) 257
thermal stability (256) 256
anti-hiv agents - pharmacokinetics (254) 254
molecular structure (251) 251
human immunodeficiency virus--hiv (249) 249
receptor, cannabinoid, cb1 - metabolism (249) 249
young adult (247) 247
chemistry, medicinal (242) 242
curing (242) 242
chemistry (241) 241
in vitro techniques (241) 241
disease models, animal (237) 237
pharmacology (235) 235
lamivudine - therapeutic use (233) 233
oxazines (233) 233
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7069) 7069
Chinese (92) 92
Japanese (60) 60
German (53) 53
French (29) 29
Spanish (24) 24
Italian (8) 8
Russian (8) 8
Dutch (7) 7
Korean (4) 4
Czech (2) 2
Portuguese (2) 2
Hungarian (1) 1
Slovak (1) 1
Ukrainian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Polymer Science Part A: Polymer Chemistry, ISSN 0887-624X, 10/2011, Volume 49, Issue 19, pp. 4213 - 4220
Journal Article
Macromolecules, ISSN 0024-9297, 02/2016, Volume 49, Issue 3, pp. 767 - 773
A novel strategy to obtain sulfur-rich polybenzoxazine copolymers by reacting allyl functional benzoxazine (BA-ala) and elemental sulfur was described.... 
MAIN-CHAIN | BENZOXAZINE MONOMERS | POLYMER SCIENCE | HIGH-PERFORMANCE THERMOSETS | MONOFUNCTIONAL BENZOXAZINE | PHENOLIC MATERIALS | MECHANICAL CHARACTERIZATION | LI-S BATTERIES | DYNAMIC COVALENT CHEMISTRY | RING-OPENING POLYMERIZATION | POLYHEDRAL OLIGOMERIC SILSESQUIOXANE
Journal Article
Journal of Polymer Science Part A: Polymer Chemistry, ISSN 0887-624X, 11/2009, Volume 47, Issue 21, pp. 5565 - 5576
Journal Article
European Polymer Journal, ISSN 0014-3057, 08/2016, Volume 81, pp. 337 - 346
[Display omitted] •Robust synthesis of a bio based bis-benzoxazine.•Allyl functionalized benzoxazine.•Tunable extended network.•Excellent thermomechanical... 
Benzoxazine | Allyl-benzoxazine | Tunable network | Chavicol | Bio-based | BIO-BASED BENZOXAZINES | POLYMERS | MONOMERS | POLYMER SCIENCE | POLYBENZOXAZINES | FINGERPRINT REGION | VIBRATIONAL ASSIGNMENTS | ALLYL GROUP | THERMAL-PROPERTIES | PHENOLIC RESIN | RING-OPENING POLYMERIZATION | Polymerization | Polymers | Formaldehyde | Networks | Phenol | Sustainability | Crosslinking | Thermosetting resins | Benzoxazines | Monomers
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 05/2018, Volume 28, Issue 9, pp. 1629 - 1637
Journal Article
European Polymer Journal, ISSN 0014-3057, 11/2018, Volume 108, pp. 48 - 56
[Display omitted] •Three bio-based benzoxazines was successfully prepared from three biphenols, furfurylamine, and paraformaldehyde.•The co-solvent of... 
Bio-based benzoxazine | Thermosets | Furfurylamine | Vanillin-derived biphenol | POLYMERS | MONOMERS | POLYMER SCIENCE | POLYBENZOXAZINES | EPOXY THERMOSETS | CHEMICAL DESIGN | FLAME-RETARDANT | VANILLIN | BIOBASED BENZOXAZINES | COPOLYMERIZATION | RENEWABLE RESOURCE | Yuan (China) | Analysis | Thermoplastics | Phenols | Biomass | Vanillin | Benzoxazines
Journal Article
European Polymer Journal, ISSN 0014-3057, 08/2015, Volume 69, pp. 636 - 641
[Display omitted] •Polybenzoxazine precursors were functionalized by thiol-oxazine reaction.•100% atom economy and availability of wide range of thiol... 
Functional polymers | Ring-opening polymerization | Post modification | Polybenzoxazine | Thiol-benzoxazine reaction | ADHESION | POLYMER SCIENCE | BENZOXAZINE MONOMER | Polybenzoicazine | THERMAL-PROPERTIES | THERMOSETS | ENE | Polymers | Thiols | Polymer industry | Activated | Precursors | Strategy | Thermosetting resins | Polybenzoxazines | Benzoxazines | Ring opening
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 01/2016, Volume 44, Issue 1, pp. 151 - 161
Efavirenz (EFV) is principally metabolized by CYP2B6 to 8-hydroxy-efavirenz (8OH-EFV) and to a lesser extent by CYP2A6 to 7-hydroxy-efavirenz (7OH-EFV). So... 
400 MG | THERAPY | CYP2B6 | MORPHINE | LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY | MORPHINE-6-GLUCURONIDE | PHARMACOLOGY & PHARMACY | ACTIVE-TRANSPORT | IDENTIFICATION | UGT2B7 | INTOXICATION | Neurotoxicity Syndromes - genetics | Reverse Transcriptase Inhibitors - blood | Humans | Anti-HIV Agents - cerebrospinal fluid | Glucuronides - cerebrospinal fluid | Cytochrome P-450 CYP2B6 - metabolism | Glucuronides - blood | Reverse Transcriptase Inhibitors - adverse effects | Tandem Mass Spectrometry | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - urine | Cytochrome P-450 CYP3A - genetics | Benzoxazines - pharmacokinetics | Sulfates - blood | HIV Infections - diagnosis | Benzoxazines - blood | Anti-HIV Agents - blood | Reverse Transcriptase Inhibitors - urine | Metabolic Detoxication, Phase II | Hydroxylation | Risk Assessment | Cytochrome P-450 CYP2A6 - genetics | Cytochrome P-450 CYP2B6 - genetics | Anti-HIV Agents - adverse effects | Benzoxazines - cerebrospinal fluid | Benzoxazines - adverse effects | Cytochrome P-450 CYP2A6 - metabolism | Genotype | Glucuronides - urine | Anti-HIV Agents - urine | Reverse Transcriptase Inhibitors - cerebrospinal fluid | Sulfates - cerebrospinal fluid | Metabolomics - methods | Neurotoxicity Syndromes - etiology | Phenotype | Sulfates - urine | Cytochrome P-450 CYP3A - metabolism | Anti-HIV Agents - pharmacokinetics | Metabolic Detoxication, Phase I | Neurotoxicity Syndromes - metabolism | HIV Infections - drug therapy | HIV Infections - metabolism | Index Medicus
Journal Article